CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.03), $0.06 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $79.2 million versus the consensus estimate of $78.09 million.

GUIDANCE:

CareDx sees FY2022 revenue of $330-350 million, versus the consensus of $343 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.